Dilaudid (hydromorphone) is roughly five times stronger than heroin on a milligram-for-milligram basis. A clinical study comparing the two drugs in cancer patients with postsurgical pain found that 1 to 2 mg of hydromorphone produced the same pain relief as 5 to 10 mg of heroin. Both drugs act on the same receptors in the brain, produce similar effects, and carry similar risks, but hydromorphone achieves those effects at a much smaller dose.
How the Potency Comparison Works
When pharmacologists say one opioid is “stronger” than another, they mean it takes fewer milligrams to produce the same effect. The standard reference point is morphine. Oral hydromorphone is about 5 times as potent as oral morphine, while injected hydromorphone is roughly 18 times as potent. Heroin (diacetylmorphine) falls between morphine and hydromorphone: 1 mg of injected heroin is equivalent to about 1.5 mg of injected morphine, or 3 mg of oral morphine.
Put another way, if you lined up all three drugs by strength per milligram, the ranking would be hydromorphone at the top, heroin in the middle, and morphine at the bottom. A direct head-to-head trial in patients confirmed this, finding hydromorphone about 5 times as potent as heroin with “similar profiles of action.” Side effects were comparable between the two, with drowsiness being the most common.
Why They Feel Similar Despite the Potency Gap
Higher potency per milligram does not mean a dramatically different experience. A clinical pharmacology study that gave both drugs to opioid-experienced individuals found that heroin and hydromorphone “produced similar effects, had similar time courses, peak effect times, onsets of action, and approximately parallel dose-response curves on most measures.” The drugs were tracked for three hours after administration, and their profiles overlapped closely.
This makes sense biologically. Both drugs ultimately activate the same target in the brain: the mu-opioid receptor. Heroin is actually a prodrug, meaning the body rapidly converts it into morphine and another active compound before it does its work. Hydromorphone binds to that same receptor directly and with high affinity, which is why less of it is needed. But once the receptor is activated to the same degree, the downstream effects (pain relief, euphoria, sedation, slowed breathing) are essentially the same.
Why the Strength Difference Matters for Risk
A drug that is active at very small doses leaves almost no room for error. The typical starting dose of Dilaudid by injection is just 1 to 2 mg. For someone without opioid tolerance, even that modest-sounding number can be dangerous. The FDA labels respiratory depression (dangerously slowed breathing) as the primary hazard of hydromorphone, and notes that “even moderate therapeutic doses may dangerously decrease pulmonary ventilation” in vulnerable people, including the elderly and anyone with a lung condition.
The high-concentration formulation of injectable Dilaudid carries an explicit warning: it is only for patients who are already taking large amounts of opioids. Giving it to someone without tolerance can be fatal. This narrow margin between an effective dose and a lethal dose is what makes hydromorphone’s potency so dangerous in practice.
Street Heroin vs. Pharmaceutical Hydromorphone
The potency comparison above assumes pure drugs at known doses. In the real world, that assumption holds for pharmaceutical hydromorphone (Dilaudid comes in precise, standardized tablets and vials) but almost never holds for street heroin. According to DEA laboratory analysis from 2024, the average purity of powder heroin samples was just 27%, and tar heroin averaged 35%. Heroin pressed into tablets was even weaker, averaging only 7% purity with some samples as low as 1%.
This means a person buying heroin on the street is getting a product that is mostly filler, and the actual heroin content varies wildly from one batch to the next. A bag that is 27% pure delivers a very different dose than one that happens to be 60% pure, even if both weigh the same. Pharmaceutical hydromorphone, by contrast, delivers exactly the labeled dose every time. That predictability cuts both ways: it eliminates the risk of an unexpectedly strong batch, but it also means that someone who misjudges their tolerance or takes an extra tablet faces a precise, potent dose with no margin of error.
The other major variable with street heroin is contamination. Illicit heroin is now frequently mixed with fentanyl or its analogues, which are far more potent than either heroin or hydromorphone. A person who believes they are comparing the effects of heroin and Dilaudid may actually be experiencing fentanyl without knowing it, which changes the risk calculation entirely.
Tolerance and Dependence
Both drugs produce physical dependence with repeated use, and both carry a high potential for addiction. Because hydromorphone is more potent per milligram, people who develop tolerance to it need escalating doses of an already-powerful drug to achieve the same effect. Withdrawal symptoms from both drugs are similar: muscle aches, nausea, anxiety, insomnia, and intense cravings. These symptoms typically begin within 6 to 12 hours after the last dose for short-acting formulations of either drug and peak around 24 to 72 hours.
The clinical research consistently supports the conclusion that hydromorphone and heroin are pharmacologically interchangeable at appropriate dose adjustments. The study in cancer patients explicitly stated that “either drug may adequately substitute for the other.” The practical difference is that one comes in a controlled pharmaceutical form and the other, in its illicit form, is unpredictable in purity, composition, and strength.